Safety Study of the Combination of Panitumumab, Irinotecan and Everolimus in the Treatment of Advanced Colorectal Cancer (PIE)

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2011 by The Queen Elizabeth Hospital
Sponsor:
Collaborators:
Amgen
Novartis
Information provided by:
The Queen Elizabeth Hospital
ClinicalTrials.gov Identifier:
NCT01139138
First received: May 28, 2010
Last updated: August 4, 2011
Last verified: July 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2015
  Estimated Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)